Myriad Genetics Inc. (MYGN) fell -6.24% or -2.56 to $38.45. It is close to 1.67 million shares traded, which is 242.98% compare to the average total volume 689130. The market cap of MYGN is $2.66 billion. The year to date change is 17.47%. The 52 week price range is from $15.15 to $41.57. Price of MYGN have changed 2.83% during last week. It have changed 19.95% over last month, 20.80% over last 3 months, 72.75% over last 6 months and 157.60% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for MYGN is 34.63. It is -9.93% below current price. The 200-day Moving Averages for MYGN is 28.87. It is -24.92% below current price. The 52-week High is 41.57. It is 8.11% from the current price. The 52-week Low is 15.15. It is -60.60% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of MYGN is 21.58 on 2018-01-12. Short % to float is 19.89%. There are some statistics of MYGN. It is has market cap $2.66 billion. The share outstanding is 69.24 million. The average volume is 689130. The revenue is 587.60M. The gross profit is 457.70M. The percent of top 15 Institution holding is 98.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of MYGN is 12.70%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of MYGN is 8.15%.